1. Functional role of long non-coding RNA CASC19/miR-140-5p/CEMIP axis in colorectal cancer progressionin vitro
    Xiao-Dong Wang et al, 2019, World Journal of Gastroenterology CrossRef
  2. Tailor‐Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma
    Xi Hu et al, 2021, Advanced Science CrossRef
  3. Recent advances in drug delivery and targeting for the treatment of pancreatic cancer
    Nilkamal Pramanik et al, 2024, Journal of Controlled Release CrossRef
  4. An Improved Ocular Impression Cytology Method: Quantitative Cell Transfer to Microscope Slides Using a Novel Polymer
    Adam Master et al, 2022, Current Eye Research CrossRef
  5. From HDAC to Voltage-Gated Ion Channels: What’s Next? The Long Road of Antiepileptic Drugs Repositioning in Cancer
    Michele Pellegrino et al, 2022, Cancers CrossRef
  6. Multipronged activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression and angiogenesis in vitro
    A. K. M. Nawshad Hossian et al, 2018, Scientific Reports CrossRef
  7. A Network Pharmacology-Based Analysis of Multi-Target, Multi-Pathway, Multi-Compound Treatment for Ovarian Serous Cystadenocarcinoma
    Dan-dan Xiong et al, 2018, Clinical Drug Investigation CrossRef
  8. Phospho-Aspirin (MDC-22) inhibits pancreatic cancer growth in patient-derived tumor xenografts and KPC mice by targeting EGFR: Enhanced efficacy in combination with irinotecan
    Cecilia Rodriguez Lanzi et al, 2022, Neoplasia CrossRef
  9. Reviewing two decades of nanomedicine implementations in targeted treatment and diagnosis of pancreatic cancer: An emphasis on state of art
    Sally A. El-Zahaby et al, 2019, Journal of Controlled Release CrossRef
  10. Mapping Intellectual Structure and Research Performance for the Nanoparticles in Pancreatic Cancer Field


    Xuan Zhu et al, 2020, International Journal of Nanomedicine CrossRef